Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...

Golf, often a game of patience and calculated risks, has a way of humbling even the greatest players. Just when it seems like ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

“Traditional Japanese pillows are filled with buckwheat husks, which mold to the shape of your head and neck, providing optimal support and better airflow. Unlike memory foam, these pillows don’t trap ...

Investigators assess the impact of increasing persistent PSA levels on prostate cancer–specific mortality and all-cause ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...

Reports FY24 revenue $27.3M, consensus $26.97M. Dr. Andrea Pfeifer, CEO of AC Immune (ACIU) SA, commented: “We significantly advanced our ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

In celebration of 10 years of this award-winning comic book series, co-creators Marjorie Liu & Sana Takeda reflect upon the ...